← All Topics / ade

FDA ADE reports for sarolaner (isoxazoline ectoparasiticide (flea/tick)) — total reports, species & reaction breakdown

ade_sarolaner_adverse_events

ade 221 tok en 2026-07-21

sarolaner — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-21. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. sarolaner is a isoxazoline ectoparasiticide (flea/tick).

Total reports

sarolaner: 79692

Reports by species (top entries)

  • Dog 67742
  • Cat 8207
  • Human 143
  • Rabbit 3
  • Bobcat 2
  • Lynx 2

Top reported reactions (VEDDRA terms, top entries)

  • Vomiting 13516
  • Seizure NOS 7249
  • Lack of efficacy (bacteria) - Borrelia 6736
  • Lack of efficacy (endoparasite) - heartworm 6178
  • Diarrhoea 5497
  • Lack of efficacy (endoparasite) - hookworm 4379
  • Lack of efficacy (ectoparasite) - tick NOS 4305
  • Lethargy (see also Central nervous system depression in 'Neurological') 4241
  • Lack of efficacy (endoparasite) - roundworm NOS 3464
  • Lack of efficacy (ectoparasite) - flea 3404

"Lack of efficacy" terms denote product-performance reports, not adverse reactions.

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-21.json (openFDA animalandveterinary/event.json, pulled 2026-07-21).

Sources

  • openFDA animalandveterinary/event.json (FDA CVM adverse event reports), pulled 2026-07-21